Intrinsic Value

Titan Pharmaceuticals, Inc. (TTNP)


+0.03 (+2.94%)

Enterprise Value -8,697,259.79
Net Debt -5.74
Equity Value -8,697,254.05
Shares Outstanding 9.73
Equity Value Per Share -893,859.61

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt